Garrett Gray - Chief Financial Officer, Checkpoint Therapeutics, Inc

As of February 5, 2021


Garrett Gray Net Worth

  • Net worth is estimated to be at least $1.26M
  • Owns at least 482,170 units of Checkpoint Therapeutics, Inc stock
  • Sold an estimated value of $137.15K in the last 3 years at Checkpoint Therapeutics, Inc

Garrett Gray Compensation at Checkpoint Therapeutics, Inc in 2020

  • Earned a $210,000 salary
  • Rewarded $381,510 in stock value and options
  • Received a total compensation of $677,506

Garrett Gray Trading

  • Largest sale of shares was 26,320 units , worth over $96.32K on February 5, 2021
  • In total has made about 7 transactions over 3 years
  • Usually trades in February, with the busiest year in 2020
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

Garrett Gray Mailing Address

  • Mailing address is 2 Gansevoort Street, 9th Floor New York NY 10014 NY

Checkpoint Therapeutics, Inc Executive Compensation

Name
Year
Salary
Bonus
Stock Awards
Other Earnings Plans or Compensations
Other Compensation
Total
James F. Oliviero III 2020 $515,000 - $1,453,140 $319,300 - $2,287,440
James F. Oliviero III 2019 $480,000 - $1,576,250 $252,000 - $2,308,250
William Garrett Gray 2020 $210,000 - $381,510 $78,120 $7,876 $677,506
William Garrett Gray 2019 $185,000 - $292,500 $56,888 $7,960 $542,348
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/1651407/000110465921058037/tm2111568-2_def14a.htm

Checkpoint Therapeutics, Inc Insider Trading

  • The most recent transaction was 118,790 units sold on February 5, 2021 by James F. Oliviero III worth over $412.27K
  • In the last 3 years, insiders at Checkpoint Therapeutics, Inc sold an estimated value of $549.42K and bought an estimated value of $356.21K
  • The most active traders are Garrett Gray, Chief Financial Officer,  MD Lindsay Rosenwald, Director,  and James F. Oliviero III, CEO
  • Insider trading is most common in June, with the busiest year in 2020 and 2021

Checkpoint Therapeutics, Inc. Insider Trades

Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1